Stay updated with breaking news from Jacobs Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Calamos Wealth Management LLC bought a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 4,339 shares of the biopharmaceutical company’s stock, valued at approximately $373,000. A number of other hedge funds have […]
Walkner Condon Financial Advisors LLC bought a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 2,622 shares of the biopharmaceutical company’s stock, valued at approximately $225,000. A number of […]
Should You Buy or Sell Gilead Sciences Stock? Get The Latest GILD Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.
Strs Ohio lowered its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 3.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 683,956 shares of the biopharmaceutical company’s stock after selling 27,672 shares during the period. Strs Ohio owned about […]
Whittier Trust Co. decreased its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 15.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 57,571 shares of the biopharmaceutical company’s stock after selling 10,614 shares during the quarter. Whittier […]